Sherif Salah

Beyond Insulin: GLX10 and the Future of Diabetes Treatment

• Broschiertes Buch

Produktbeschreibung

The development of an effective vaccine for Type 2 Diabetes Mellitus stands as a revolutionary milestone in modern medicine, offering the promise of transforming how this chronic disease is understood and managed. Such a vaccine, capable of providing long-term immunity to individuals predisposed to the condition whether through genetic or environmental factors.This breakthrough extends far beyond the realm of diabetes itself. The creation of a vaccine for a disease long deemed incurable has the potential to open new avenues for treating other chronic and elusive conditions, ushering in an era of innovative, patient-centered medicine. The significance of this achievement is not confined to alleviating suffering or improving the quality of life for millions of patients; it also serves as a powerful catalyst for advancing scientific inquiry. By addressing the root causes of chronic diseases, such as systemic inflammation and mitochondrial dysfunction, this innovation paves the way for a deeper understanding of human health and the development of comprehensive, lasting solutions.

Produktdetails

• Verlag: LAP Lambert Academic Publishing
• Seitenzahl: 204
• Erscheinungstermin: 15. Januar 2025
• Englisch
• Abmessung: 220mm x 150mm x 13mm
• Gewicht: 322g
• ISBN-13: 9786208065782
• ISBN-10: 620806578X
• Artikelnr.: 73287135

Autorenporträt

Sherif Salah is a distinguished scientist and consultant in Clinical Pathology, boasting a comprehensive educational background with an MD & Ph.D. in immunology, along with Diplomas in clinical Pathology, Bacteriology, and Vit. Medicine from Cairo University. He is recognized as an innovator in the field, having developed numerous pharmaceuticals.